Changeflow GovPing Healthcare Regulation Strattera Oral Solution SMPC Posting
Routine Notice Added Final

Strattera Oral Solution SMPC Posting

Favicon for www.regulations.gov Regs.gov: Food and Drug Administration
Published March 13th, 2026
Detected March 15th, 2026
Email

Summary

The FDA has posted the Summary of Product Characteristics (SMPC) for Strattera oral solution on March 13, 2026. This posting provides updated information regarding the drug's characteristics and usage. It is intended for informational purposes for drug manufacturers and healthcare professionals.

View original document View source feed page

What changed

The U.S. Food and Drug Administration (FDA) has posted the Summary of Product Characteristics (SMPC) for Strattera oral solution, with the posting date of March 13, 2026. This document, identified by FDA-2026-P-2639-0005, serves as an informational update regarding the drug's profile.

This posting is primarily for informational purposes and does not appear to introduce new compliance obligations or deadlines for drug manufacturers. Compliance officers should note this update for their records related to pharmaceutical product information. No specific actions or penalties are indicated in the provided document.

Source document (simplified)

Content

Download File

Download

Related changes

Favicon for www.regulations.gov PCLOB Forum on Financial Tools, Privacy, and Civil Liberties
Priority review Mar 15, 2026 • Regs.gov: Privacy and Civil Liberties Oversight Board • Data Privacy
Favicon for www.regulations.gov FISA Section 702 Comment Period Extended
Routine Mar 15, 2026 • Regs.gov: Privacy and Civil Liberties Oversight Board • Data Privacy
Favicon for www.regulations.gov PCLOB Meeting Notice on Classified Matters and Counterterrorism
Routine Mar 15, 2026 • Regs.gov: Privacy and Civil Liberties Oversight Board • Data Privacy
Favicon for www.federalregister.gov DEA: Controlled Substances Manufacturer Application for Patheon API Services Inc
Priority review Mar 14, 2026 • FR: Justice Department • Legal Enforcement
Favicon for www.federalregister.gov Importer of Controlled Substances Application: Lonza Tampa, LLC
Priority review Mar 14, 2026 • FR: Justice Department • Legal Enforcement
Favicon for www.federalregister.gov DEA: Bulk Manufacturer Controlled Substances Application Pisgah Laboratories Inc
Priority review Mar 14, 2026 • FR: Justice Department • Legal Enforcement

Source

Favicon for www.regulations.gov
Regs.gov: Food and Drug Administration regulations.gov/search?agencyIds=FDA&sortBy=postedDate&sortDirection=desc
Healthcare Regulation
Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
Various Federal Agencies
Published
March 13th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Drug manufacturers
Geographic scope
National (US)

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Compliance
Topics
Drug Labeling FDA

Browse Categories

Federal Courts 25 State Courts 91 Securities Regulation 7 Financial Regulation 75 Consumer Protection 7 Drug Safety 45 Data Protection 21 Competition 2 Attorneys General 3 Insurance Regulation 5 Trade & Export 36 Legislation 43 Energy Regulation 42 Environment 3 Labor & Employment 2 Tax 1

Get Healthcare Regulation alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when Regs.gov: Food and Drug Administration publishes new changes.

Free. Unsubscribe anytime.